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Purpose: To clarify the effects on the visual pathway that occur following retinal damage, we examined the morphological
alterations present in the superior colliculus (SC) after N-methyl-D-aspartate (NMDA)-induced retinal damage in mice.
Methods: NMDA was injected into the vitreous body of the left eye in mice to induce retinal damage. The time-dependent
neuronal degeneration in the SC was assessed using immunohistochemistry.
Results: The number of neuronal nuclear specific protein (NeuN)-immunostained neurons showed a significant decrease
in the contralateral SC at both 90 and 180 days after intravitreal NMDA injection. In contrast, the ipsilateral SC displayed
no  significant  change  in  the  number  of  NeuN-positive  cells.  An  increase  in  glial  fibrillary  acid  protein  (GFAP)
immunoreactivity was observed in the contralateral SC at 7, 30, and 90 days after NMDA injection and in the ipsilateral
SC at 7 days, while brain-derived neurotrophic factor (BDNF) expression was increased in the contralateral SC at 30 and
90 days. In the contralateral SC, some GFAP-positive astroglial cells also exhibited BDNF at 30 days after NMDA
injection.
Conclusions: Evidence of time-dependent morphological neuronal degeneration along the retinocollicular pathway from
the retina to the SC was detected at 90 and 180 days, but not at 30 days, after NMDA-induced retinal damage. This
neurodegeneration was preceded by an increase in BDNF expression in the SC, specifically at 30 and 90 days after NMDA
injection. Hence, these findings may provide useful information concerning the pathological mechanisms of several
disorders accompanied by retinal degeneration.
The superior colliculus (SC), a major target of primary
optic  projections,  plays  an  important  role  in  guiding  the
movements of the eye, ear, and head [1,2]. In the SC, there are
three main types of sites: the superficial, intermediate, and
deep layers. In some species, the superficial layer receives
input from both the contralateral and the ipsilateral retinas
[3], although in most mammalian species the projection to the
superficial layer is from the contralateral retina. At least 70%
of retinal ganglion cells (RGC) have been found to project to
the SC in mice [4]. Since the superficial layer of the SC is
innervated by axons from the retina, their input is almost
exclusively related to vision.
RGC death is a common feature of many ophthalmic
disorders, such as glaucoma, optic neuropathies, and various
retinovascular diseases (diabetic retinopathy and retinal vein
occlusions).  RGC  death  may  occur  via  a  variety  of
mechanisms involving, for example, reactive oxygen species
[5], excitatory amino acids [6], nitric oxide [7], and apoptosis
[8].
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Glutamate is the principal excitatory neurotransmitter in
the central nervous system and retina. Excessive activation of
glutamate receptors by glutamate released from injured RGC
is implicated in the glaucomatous RGC death process [9].
These  findings  indicate  that  glutamate  is  associated  with
damage to the eye and brain. In a recent study on mice, we
found that the cell number in the ganglion cell layer decreased
and  retinal  damage  occurred  within  seven  days  after
intravitreal NMDA injection; at the same time, the number of
neurons  in  the  lateral  geniculate  nucleus,  the  major  relay
center between the eye and the visual cortex, decreased at 90
days after injection [10]. However, to our knowledge, no
previous  investigation  has  been  made  of  time-dependent
alterations along the collicular visual pathways after retinal
injury in mice. Clarification of this pathogenesis could help to
elucidate the mechanism responsible for blindness caused by
various ophthalmic disorders (e.g., glaucoma).
Neurotrophins, originally identified for their ability to
promote  neuronal  survival  and  differentiation,  are  potent
modulators of synaptic connectivity in the central nervous
system, influencing synaptic structure and function [11,12].
Specifically, BDNF influences the morphological complexity
of axons and dendrites [13-15], modulates synapse maturation
[16,17], increases the number of synapses in the developing
brain [18,19], and controls the ultrastructural composition of
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662synapses [20,21]. Thus, BDNF is involved in multiple aspects
of  synaptogenesis,  from  formation  to  the  functional
maturation of synapses. Reportedly, endogenous BDNF in the
dorsal root ganglia and spinal cord is required for the enhanced
regeneration of ascending sensory neurons after conditioning
lesions of the sciatic nerve, and peripherally applied BDNF
may have therapeutic effects on spinal cord injuries [22]. In
our previous study, intravitreal injection of BDNF inhibited
RGC damage after axotomy [23]. However, to our knowledge,
there  are  no  reports  regarding  the  role  of  BDNF  in  the
subsequent neuron loss in the SC after retinal damage. We
therefore designed the present study to examine the time-
dependent  morphological  and  immunohistochemical
alterations and changes in BDNF expression occurring in the
murine SC after intravitreal injection of NMDA.
METHODS
Animals: Male adult (6 week-old) C57BL/6J mice weighing
20−32 g (Japan Clea, Inc. Fujimiya, Japan) were kept under
lighting conditions of 12 h light and 12 h dark. The house or
the cage was 17×30×14 cm, food from CE-2 (Japan Clea, Inc.
Fujimiya, Japan), and 500 ml/8 mice/week amount of water
was given to mice.
All experiments were performed in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and were approved and monitored by the
Institutional  Animal  Care  and  Use  Committee  of  Gifu
Pharmaceutical University.
NMDA  Injection:  Mice  were  anesthetized  (46  mice)  with
3.0% isoflurane (Merck, Osaka, Japan) and maintained with
1.5% isoflurane in 70% N2O and 30% O2 via an animal general
anesthesia apparatus (Soft Lander; Sin-ei Industry Co. Ltd.,
Saitama, Japan). Retinal damage was induced by intravitreal
injection of 2 µl NMDA (Sigma-Aldrich, St. Louis, MO)
dissolved  at  20  mM  in  0.01  M  phosphate-buffered  saline
(PBS; containing 2.7 mM KCl, 1.5 mM KH2PO4, 136.8 mM
NaCl, and 8.1 mM Na2HPO4-12H2O) at pH 7.4. This was
injected into the vitreous body of the left eye while the mouse
was under anesthesia (Figure 1). One drop of levofloxacin
ophthalmic solution (Santen Pharmaceuticals Co. Ltd., Osaka,
Japan) was applied topically to the treated eye immediately
after  the  intravitreal  injection.  NMDA-treated  mice  were
euthanized at 3 (n=5), 7 (n=4), 30 (n=6), 90 (n=5), and 180
days (n=11). The control (untreated) group (n=13) consisted
of mice euthanized at 1 (n=4), 30 (n=3), 90 (n=3), and 180
days (n=3). The sham group was composed of mice who
received intravitreal injection of PBS instead of NMDA. This
group was euthanized at 3 (n=3), 7 (n=3), 30 (n=3), 90 (n=3),
and 180 days (n=3).
Sample  preparation:  At  the  end  of  the  assigned  survival
periods,  mice  were  euthanized  with  an  intraperitoneal
injection  of  80  mg/kg  sodium  pentobarbital  (Nembutal;
Dainippon,  Osaka,  Japan)  and  perfused  with  4%  (w/v)
paraformaldehyde solution in 0.01 M PBS (except for the
immunohistochemistry  of  BDNF,  when  2%  [w/v]
paraformaldehyde solution in 0.01 M PBS was used). The
brains  were  removed  after  a  15  min  perfusion  at  4  °C,
immersed in the same fixative solution for 24 h, soaked in 25%
(w/v)  sucrose  for  1  day,  and  then  frozen  in  embedding
compound  (Tissue-Tek;  Sakura  Finetechnical  Co.  Ltd.,
Tokyo,  Japan).  Coronal  sections  through  the  SC  (bregma
−3.40 mm) were cut in 10 µm thicknesses (Figure 1).
Immunohistochemistry: For immunohistochemistry, coronal
sections containing the SC were placed on slides (Mascoat;
Matsunami, Osaka, Japan), washed with 0.01 M PBS, and
then treated with 0.3% hydrogen peroxidase in methanol for
30 min at room temperature. Next, the sections were blocked
with  mouse-on-mouse  blocking  reagent  (M.O.M.
Figure 1. The projection pathway from
the retina to the SC. Illustrations show
(A) the pathway from the retina to the
superior colliculus (SC), (B) the coronal
section  through  the  level  of  the  SC
(bregma−3.40 mm) in mice; boxed areas
contain the SC of the contralateral side
and  the  ipsilateral  side  and  (C)  the
superficial layer of the SC.
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663immunodetection kit; Vector Laboratories, Inc., Burlingame,
CA) and then incubated either with 1: 250 dilution mouse anti-
NeuN monoclonal antibody (Chemicon, Temecula, CA) or
with mouse anti-GFAP monoclonal antibody (Ylem, Rome,
Italy) for 1 day at 4 °C. They were washed with 0.01 M PBS
and then incubated with biotinylated anti-mouse IgG before
being incubated with the avidin-biotin-peroxidase complex
for 30 min at room temperature, and finally visualized using
diamino benzidine (DAB) as a peroxidase substrate (Vector
Laboratories).
In the immunostaining procedures for BDNF, coronal
sections containing the SC were washed with 0.01 M PBS
containing  0.05%  Tween-20  and  then  treated  with  0.3%
hydrogen  peroxidase  in  methanol.  Next,  they  were
preincubated with 10% normal goat serum (Vector) in 0.01 M
PBS for 30 min and then incubated for one day at 4 °C with
1:1,000 specific rabbit anti-BDNF polyclonal antibody [24]
in the following solution: 10% normal goat serum in 0.01 M
PBS containing 0.3% (v/v) Triton X-100. They were washed
with  0.01  M  PBS  containing  0.05%  Tween-20  and  then
incubated  with  biotinylated  anti-rabbit  IgG  before  being
incubated with the avidin-biotin-peroxidase complex for 30
min at room temperature, and finally visualized using DAB
as a peroxidase substrate.
To visualize the colocalization of BDNF with NeuN or
GFAP, we performed double immunofluorescence on the SC
sections  from  the  NMDA-treated  mice.  Coronal  sections
containing the SC were washed with 0.01 M PBS and 0.05%
Tween-20 then treated with 0.3% hydrogen peroxidase in
methanol for 30 min at room temperature. Next, they were
preincubated with 10% normal goat serum in PBS for 30 min
and then incubated overnight at 4 °C with 1:1,000 dilution
rabbit  anti-BDNF  monoclonal  antibody  in  the  following
solution: 10% normal goat serum in PBS with 0.3% (v/v)
Triton  X-100.  The  sections  were  blocked  with  M.O.M.
blocking reagent and incubated either with 1:250 mouse anti-
NeuN monoclonal antibody (Chemicon) or with 1:250 mouse
anti-GFAP monoclonal antibody (Ylem) for 1 day at 4 °C.
They  were  washed  with  0.01  M  PBS  containing  0.05%
Tween-20 and incubated for 3 h at room temperature with a
mixture of 1:1,000 dilution Alexa Fluor 488 F(ab’)2 fragment
of goat anti-rabbit IgG (H+L; Molecular Probes, Eugene, OR)
and 1:1,000 dilution Alexa Fluor 488 F(ab’)2 fragment of goat
anti-mouse IgG (H+L; Molecular Probes).
Total images of the SC were taken using a microscope
(BX50; Olympus, Tokyo, Japan) fitted with 10X and 40X
microscope objective lenses. The images visualized by DAB
were taken using a digital camera (Coolpix 4500; Nikon,
Toyko, Japan), and immunofluorescence images were taken
using a charge-coupled device camera (DP30BP; Olympus)
at 1,360×1,024 pixels via Metamorph (Universal Imaging
Corp., Downingtown, PA). NeuN and BDNF-positive cells
and  GFAP-positive  astroglial  cells  were  counted  in  the
superficial layer of the SC by a single observer (H.T.), as in
our previous report [10]. Counted sections were shown in
Figure 1 (bregma −3.40 mm and 10 µm thickness). Data were
counted and averaged using three sections of each animal. The
results were expressed as positive cells per 1 mm2.
Data analysis: Data are presented as means±SEM. Statistical
comparisons (one-way ANOVA followed by a Dunnett’s test)
were made using STAT View version 5.0 (SAS Institute, Inc.,
Cary, NC). A value of p<0.05 was considered to indicate
statistical significance.
RESULTS
Neuronal Cells Immunostained for NeuN: NeuN, an antibody
known as a neuron-specific antigen, selectively and clearly
stains neuronal perikarya and nuclei [25]. NeuN and Nissl
staining  produce  highly  correlated  estimates  of  neuronal
density, size, and shape [26]. Furthermore, NeuN may be
particularly useful when it is important to distinguish small
neurons from glial cells. In our control mice, NeuN-positivity
was seen in almost all neurons within the superficial layer of
the  SC  (Figure  2A).  In  the  NMDA-treated  group,  NeuN-
labeled neurons were first seen to be significantly decreased
in number in the contralateral SC at 90 days after NMDA
injection; the number decreased to 69.2% (90 days) and 68.1%
(180 days) of control after NMDA injection (Figure 2B). In
contrast,  no  significant  decrease  in  the  number  of  NeuN-
labeled  neurons  (versus  control)  was  observed  in  the
superficial layer of the ipsilateral SC at 3, 7, 30, 90, and 180
days (Figure 2B). Furthermore, no morphological differences
in the SC were observed among the control and sham-treated
mice (data not shown).
Astrocytes  Immunostained  for  GFAP:  Activation  of
astrocytes could be easily detected by staining with antibodies
against  GFAP.  We  investigated  the  time-dependent
alterations of activated astrocytes in the superficial layer of
the SC by immunohistochemical analysis (Figure 3) At 3, 7,
30, and 90 days and 3, 7, and 30 days after NMDA injection,
GFAP  expression  was  observed  in  the  contralateral  and
ipsilateral SC, respectively (Figure 3A). Quantitative analysis
of GFAP-positive astroglial cells is shown in Figure 3B. The
number of GFAP-positive astroglial cells was significantly
increased (versus control) in the contralateral SC at both 7 and
30 days and in the ipsilateral SC at 7 days after NMDA
injection (Figure 3B). No morphological differences in the SC
were observed among the control and sham-treated mice (data
not shown).
BDNF Expression in SC Cells: The specificity of the antibody
against  BDNF  employed  in  this  experiment  has  been
characterized  using  immunohistochemistry  and  western
blotting [24]. The antibody was unique to BDNF and did not
detect other neurotrophins. To examine the time-dependent
changes  in  BDNF  expression,  we  performed
immunohistostaining (Figure 4). In the control mice, BDNF-
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664positive cells were observed in SC (Figure 4A), and they were
significantly increased (versus control) in the contralateral SC
at  30  and  90  days  after  NMDA  injection  (Figure  4C).
Similarly, a slight increase (versus control) was observed in
the ipsilateral SC at 90 and 180 days (Figure 4C). To identify
BDNF-positive  cells,  we  performed  double
immunofluorescence  for  BDNF  and  NeuN  using  the  SC
sections.  Some  NeuN-positive  neuronal  cells  expressed
BDNF at 30 days after NMDA injection (Figure 4B). No
morphological differences in the SC were observed among the
control and sham-treated mice (data not shown).
Double immunofluorescence: To identify other cells that were
positive  for  BDNF,  we  performed  double
immunofluorescence for BDNF and GFAP in brain sections
Figure  2.  NeuN  immunostaining  of
sections of the SC. A: Representative
microphotographs  of  the  superior
colliculus (SC) are shown for the control
group (untreated) for 180 days after N-
methyl-D-aspartate  (NMDA)  injection
(the contralateral side and the ipsilateral
side). The scale bars represent 30 µm.  B: 
The   average   number  of  neuronal
nuclear specific protein (NeuN)-labeled
neurons  was  counted  in  the  SC.  Each
value     represents     the    mean±SEM
(n=4-11). The asterisk indicates p<0.05,
while   the   double  asterisk  represents
p<0.01  versus  control (untreated mice;
Dunnett’s test).
Figure  3.  GFAP-positive  astrocyte  of
sections of the SC. A: Representative
microphotographs  of  the  superior
colliculus (SC; the contralateral side and
the ipsilateral side) are shown for the
control group (untreated) 3, 7, 30, 90,
and  180  days  after  N-methyl-D-
aspartate (NMDA) injection. The scale
bar represents 30 µm. B: The average
number of glial fibrillary acid protein
(GFAP)-positive  astrocytes  was
counted in the SC. Each value represents
the  mean±SEM  (n=3).  The  asterisk
indicates  p<0.05,  while  the  double
asterisk  represents  p<0.01  versus
control (untreated mice; Dunnett’s test).
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665containing  the  SC  after  the  intravitreal  NMDA  injection.
Some GFAP-positive astroglial cells exhibited BDNF in the
superficial  layer  of  the  contralateral  SC  at  30  days  after
NMDA injection (Figure 5).
DISCUSSION
In our previous study (also on mice), we observed a time-
dependent  decrease  in  the  number  of  RGC  after  NMDA
injection, with the damage first being evident at one day and
almost reaching a plateau at three days after the injection
[10]. These findings suggest that the neuronal degeneration
we detected here in the contralateral SC was secondary to
NMDA-induced retinal damage. It has also been reported that
removal of the SC (in neonatal Wistar rats) results in a rapid
loss of RGC, an event involving NMDA receptors [27,28]. It
is likely that, because of interactions between RGC and the
SC, the aforenamed types of neuronal degeneration result
from  a  reduction  in  mutual  stimuli  and  from  a  lack  of
neurotrophins (due to a dysfunction of anterograde transport
from RGC). In mice, most of the optic fibers are crossed
(70%–80%), and the direct retinohypothalamic projection to
the contralateral SC is three times greater than that to the
ipsilateral SC [29].
Astroglial activation is mainly characterized by marked
overexpression of the major component of the gliofilaments,
GFAP; this is a well known characteristic marker of astrocyte
activation/reactive  astrocytosis.  Previous  studies  have
revealed that transection of the optic nerve (or enucleation)
leads  to  both  fiber  and  terminal  degeneration  (Wallerian
degeneration) within the SC [30-32] and to reactive changes
in astrocytes [33,34]. Moreover, it has been reported that in
rats,  increases  in  GFAP  within  the  SC  follow  3,  3′-
iminodipropionitrile-induced retinal degeneration, which is
known to disrupt neurofilaments and axonal transport [35]. In
the  present  study,  GFAP  expression  was  increased  in  the
contralateral  SC  at  7,  30,  and  90  days  after  unilateral
intravitreal  injection  of  NMDA.  In  addition,  significant
increases in GFAP expression were observed in the ipsilateral
SC  at  7  days.  These  findings  indicate  that  the  neuronal
degeneration within the SC occurred not only contralaterally
but also ipsilaterally, because of the nature of the projection
from the retina (see Figure 1). Since damage to neuronal cells
within the SC was not detected during the period of increased
GFAP expression, reactive astrocytes may provide crucial
support for neurons during this period through such functions
as the production of trophic factors and the elimination of
toxins [36,37].
The  expression  of  neurotrophins  is  regulated  by
neuroelectric activity, and neurotrophins may modulate the
efficacy of synaptic transmission, the growth of dendrites and
axons, or the production of the structural elements necessary
for  synaptogenesis  [38-42].  BDNF,  a  member  of  the
neurotrophin family, plays a critical role in the development,
survival, and synaptic plasticity of neurons within the adult
central  nervous  system  [38,43].  BDNF  is  synthesized  by
neurons  and  then  anterogradely  transported.  Reactive
Figure  4.  BDNF-positive  cells  of
sections of the SC. A: Representative
microphotographs  of  the  superior
colliculus (SC; the contralateral side and
the ipsilateral side) are shown for the
control group (untreated) 3, 7, 30, 90,
and  180  days  after  N-methyl-D-
aspartate (NMDA) injection. The scale
bar represents 30 µm. B: Representative
photographs  show  brain-derived
neurotrophic  factor  (BDNF)  and
neuronal  nuclear  specific  protein
(NeuN)  immunostaining,  and  BDNF/
NeuN  double-immunostaining  of  the
contralateral  SC  at  30  days  after
intravitreal  NMDA  injection  in  mice.
Some  BDNF-expressing  cells  were
colocalized  with  NeuN-positive
neuronal  cells,  as  indicated  by  the
yellow color. The scale bar represents
20  µm.  C:  The  average  number  of
BDNF  immunopositive  puncta  was
counted in the SC. Each value represents
the  mean±SEM  (n=3).  The  asterisk
indicates  p<0.05,  while  the  double
asterisk  represents  p<0.01  versus
control (untreated mice; Dunnett’s test).
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666astrocytes have been shown to produce BDNF [44-47]. In the
present study, we observed significant increases in BDNF-
positive cells in the contralateral SC at 30 and 90 days after
NMDA injection, and at least a partial overlap with the cells
showing  increased  expression  of  GFAP.  These  findings,
indicating  that  BDNF  was  produced  by  GFAP-positive
astroglial  cells,  are  consistent  with  BDNF  from  reactive
astroglial cells. However, as mentioned, BDNF is known to
be synthesized by neurons and then anterogradely transported
[48-50], and to be transferred from neuron to neuron [51]. The
synthesis of BDNF is increased in RGCs immediately after
intravitreal injection of NMDA in rats [51]. BDNF injected
into the retina may be internalized by retinal ganglion neurons
and transported to the SC, where BDNF may be released and
transferred to the postsynaptic neurons [52]. In the present
study, therefore, the BDNF expression we detected may be
derived  from  GFAP-positive  astroglial  cells  and/or  from
retinal ganglion neurons.
In this experiment, we could not clarify the detailed role
of BDNF expressed in the SC after NMDA injection. In a
previous study, polysialylated neural cell adhesion molecule,
which contributes to nervous system plasticity, was expressed
in the normal adult murine SC after RGC injury and involved
in attempted visual system remodeling [53]. The BDNF gene
transferred into RGC by electroporation or BDNF injected
into the SC could prevent RGC loss after axotomy [54,55].
Further  studies  are  needed  to  clarify  the  precise  roles
Figure 5. Colocalization of BDNF with GFAP by double immunofluorescence. A: Schematic drawing shows the coronal section through the
level of the superior colliculus (SC; bregma −3.40 mm) in mice. The boxed area is the region of the superficial layer in the contralateral SC.
Representative photographs show brain-derived neurotrophic factor (BDNF; B and C) and glial fibrillary acid protein (GFAP; D and E)
immunostaining, and BDNF/GFAP (F and G) double-immunostaining of the contralateral SC at 30 days after intravitreal N-methyl-D-aspartate
(NMDA) injection in mice. Some BDNF-expressing cells (B and C, green) were colocalized with GFAP-positive astroglial cells (D and E,
red), as indicated by the yellow color in F (merge of B and D) and G (merge of C and E). The scale bars represents 50 µm (B, D, and F) or
10 µm (C, E, and G).
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667performed by BDNF in the SC during the processes leading
to SC damage following NMDA injection.
In  conclusion,  we  found  that  time-dependent
morphological alterations and increases in the expression of
BDNF occurred in the murine SC following NMDA-induced
retinal  damage.  These  findings  may  provide  useful
information  concerning  the  pathological  mechanisms  of
several disorders accompanied by retinal degeneration.
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